Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Carbon nanotubes

Fibrillar pharmacology

Nature Materials volume 9, pages 793–795 (2010)Cite this article

Subjects

The mechanisms by which chemically functionalized carbon nanotubes flow in blood and are excreted through the kidneys illustrate the unconventional behaviour of these fibrillar nanostructures, and the opportunities they offer as components for the design of advanced delivery vehicles.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: A schematic of the glomerular filtration system (a multicompartmental structure).

References

  1. Ruggiero, A. et al. Proc. Natl Acad. Sci. USA 107, 12369–12374 (2010).

    Article  CAS  Google Scholar 

  2. Kostarelos, K. et al. Nature Nanotech. 2, 108–113 (2007).

    Article  CAS  Google Scholar 

  3. Haraldsson, B., Nystrom, J. & Deen, W. M. Physiol. Rev. 88, 451–487 (2008).

    Article  CAS  Google Scholar 

  4. Singh, R. et al. Proc. Natl Acad. Sci. USA 103, 3357–3362 (2006).

    Article  CAS  Google Scholar 

  5. Lacerda, L. et al. Adv. Mater. 20, 225–230 (2008).

    Article  CAS  Google Scholar 

  6. Lacerda, L. et al. Small 4, 1130–1132 (2008).

    Article  CAS  Google Scholar 

  7. Liu, Z., Tabakman, S., Welsher, K. & Dai, H. Nano. Res. 2, 85–120 (2009).

    Article  CAS  Google Scholar 

  8. Deng, X. et al. Carbon 45, 1419–1424 (2007).

    Article  CAS  Google Scholar 

  9. Cedervall, T. et al. Proc. Natl Acad. Sci. USA 104, 2050–2055 (2007).

    Article  CAS  Google Scholar 

  10. Kostarelos, K. Nature Biotechnol. 26, 774–776 (2008).

    Article  CAS  Google Scholar 

  11. Geng, Y. et al. Nature Nanotech. 2, 249–255 (2007).

    Article  CAS  Google Scholar 

  12. Park, J. H. et al. Small 5, 694–700 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kostas Kostarelos is at the Nanomedicine Lab, Centre for Drug Delivery Research, The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX, United Kingdom. kostas.kostarelos@pharmacy.ac.uk,

    Kostas Kostarelos

Authors
  1. Kostas Kostarelos
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kostarelos, K. Fibrillar pharmacology. Nature Mater 9, 793–795 (2010). https://doi.org/10.1038/nmat2871

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nmat2871

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research